Vsee Health (VSEE) Cash & Equivalents (2022 - 2026)

Vsee Health's Cash & Equivalents history runs 5 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• Quarterly Cash & Equivalents changed N/A year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (changed N/A YoY) and the FY2024 annual result came in at $326115.0, up 174.66% from the prior year.
• Cash & Equivalents was $1.3 million for Q1 2026 at Vsee Health, up from $472759.0 in the prior quarter.
• Across five years, Cash & Equivalents topped out at $1.3 million in Q1 2026 and bottomed at $507.0 in Q3 2023.
• A 5-year average of $362162.2 and a median of $222424.5 in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents tumbled 96.8% — and 2024, when it jumped 174.66%.
• Vsee Health's Cash & Equivalents stood at $106998.0 in 2022, then advanced by 10.97% to $118734.0 in 2023, then surged by 174.66% to $326115.0 in 2024, then soared by 44.97% to $472759.0 in 2025, then surged by 184.74% to $1.3 million in 2026.
• Business Quant data shows VSEE's Cash & Equivalents at $1.3 million in Q1 2026, $472759.0 in Q3 2025, and $326115.0 in Q4 2024.